Cannabics Pharmaceuticals announced today that it has finalized a letter of engagement with Mountain High Products, a Colorado based, leading cannabis infused products manufacturer and distributor. Mountain High Products offers a diverse line of edible and concentrate products that deliver quality, consistency, and potency.
Under the letter’s terms, Cannabics Pharmaceuticals will license to Mountain High Products the exclusive right to use its proprietary Cannabics SR technology for manufacture and commercialization of the products in the Colorado market. The letter’s terms allow for discussion of additional markets for both parties to enter together upon agreement, as well. Cannabics Pharmaceuticals and Mountain High Products intend to enter into a definitive IP license agreement within the months after operations launch and the start of initial collaboration.
In its production of Cannabics SR medical cannabis products, Mountain High Products will maintain strict compliance with Colorado laws and regulations related to “cannabis infused edible products.” Additionally, these products will be distributed via Mountain High’s distribution channels to certified dispensaries.
Dr. Zohar Koren, CEO of Cannabics Pharmaceuticals, stated, “We are very excited to launch the collaboration with Mountain High Products in Colorado and thus offer our line of advanced medical cannabis products to American patients for the first time. Mountain High Products is an ideal strategic partner for us to launch US commercialization operations and by far the most professional and dedicated manufacturer of edible cannabis products in Colorado.”
Nancy Whiteman, owner of Mountain High Products added, “We are thrilled to partner with Cannabics Pharmaceuticals. From our perspective, the ability to offer an extended release option in cannabis medication will be a game changing improvement to a patient’s medical marijuana experience. The Cannabics SR technology will enable patients to have more consistent and longer lasting relief from pain, insomnia and other medical conditions without the highs and lows of other cannabis options. This is truly a huge step forward for medical marijuana.”
For more information, visit: www.cannabics.com
Let us hear your thoughts: Cannabics Pharmaceuticals, Inc. Message Board